XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.3Close
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities    
Net income $ 3,050.7 $ 4,307.1
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:    
Depreciation and amortization 1,139.6 1,147.5
Change in deferred income taxes (1,834.8) (2,195.6)
Stock-based compensation expense 508.3 278.2
Net investment losses 144.5 676.4
Gains on sale of product rights (1,853.9) (94.5)
Acquired in-process research and development 3,177.2 668.4
Other changes in operating assets and liabilities, net of acquisitions and divestitures 117.2 823.4
Other operating activities, net 103.2 312.1
Net Cash Provided by Operating Activities 4,552.0 5,923.0 Close
Cash Flows from Investing Activities    
Purchases of property and equipment (2,377.0) (1,353.6)
Proceeds from sales and maturities of short-term investments 155.2 83.1
Purchases of short-term investments (79.2) (65.0)
Proceeds from sales of and distributions from noncurrent investments 476.2 251.6
Purchases of noncurrent investments (474.8) (474.1)
Proceeds from sale of product rights 1,604.3 65.8
Purchases of in-process research and development (3,364.0) (993.1)
Other investing activities, net (169.1) (334.1)
Net Cash Used for Investing Activities (4,228.4) (2,819.4) Close
Cash Flows from Financing Activities    
Dividends paid (3,051.2) (2,651.4)
Net change in short-term borrowings 97.0 1,741.3
Proceeds from issuance of long-term debt 3,958.5 0.0
Repayments of long-term debt 0.0 (1,560.0)
Purchases of common stock (750.0) (1,500.0)
Other financing activities, net (303.4) (295.2)
Net Cash Used for Financing Activities (49.1) (4,265.3) Close
Effect of exchange rate changes on cash and cash equivalents 39.3 (39.4) Close
Net increase (decrease) in cash and cash equivalents 313.8 (1,201.1) Close
Cash and cash equivalents at January 1 2,067.0 3,818.5
Cash and Cash Equivalents at September 30 $ 2,380.8 $ 2,617.4